Mahamaya Lifesciences IPO
Mahamaya Lifesciences IPO Details
-
Open Date
11 Nov 2025
-
Close Date
13 Nov 2025
-
Listing Date
18 Nov 2025
- IPO Price Range
₹ 108 to ₹114
- IPO Size
₹ 70.44 Cr
- Listing Exchange
BSE SME
Mahamaya Lifesciences IPO Timeline
Mahamaya Lifesciences IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 11-Nov-2025 | 0.00 | 0.35 | 0.07 | 0.11 |
| 12-Nov-2025 | 0.65 | 0.27 | 0.20 | 0.34 |
| 13-Nov-2025 | 1.19 | 3.63 | 1.02 | 1.63 |
Last Updated: 13 November 2025 6:06 PM by 5paisa
Mahamaya Lifesciences Limited, established in 2002 and headquartered in New Delhi and Gurugram, Haryana, specialises in high-quality agricultural crop protection solutions. The company focuses on manufacturing and marketing agrochemicals, including herbicides, insecticides, fungicides, and plant growth regulators. With a strong emphasis on environmentally compatible solutions, Mahamaya represents world-class overseas manufacturers exclusively for the Indian market. It serves both domestic and international markets, offering a wide range of formulations and raw materials to enhance Indian agriculture. The company operates with a global vision and is guided by experienced promoters.
Established in: 2002
Managing Director: Krishnamurthy Ganeshan
Mahamaya Lifesciences Objectives
• Purchase of Equipment for existing Formulation plant (₹3.65 Cr)
• Funding capital expenditure towards setting up of a new technical manufacturing plant. (₹29.42 Cr)
• Construction of Warehouse Building and Purchase of Machinery (₹2.52 Cr)
• Funding working capital requirement of our Company (₹18 Cr)
• General Corporate purposes
Mahamaya Lifesciences IPO Size
| Types | Size |
|---|---|
| Total IPO Size | ₹70.44 Cr |
| Offer For Sale | ₹6.15 Cr |
| Fresh Issue | ₹64.28 Cr |
Mahamaya Lifesciences IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2400 | ₹2,59,200 |
| Retail (Max) | 2 | 2400 | ₹2,73,600 |
| S - HNI (Min) | 3 | 3600 | ₹3,88,800 |
| S - HNI (Max) | 7 | 8400 | ₹9,57,600 |
| B - HNI (Min) | 8 | 9600 | ₹10,94,400 |
Mahamaya Lifesciences IPO Reservation
| Investors Category | Subscription (times) | Shares Offered* | Shares bid for | Total Amount (Cr.)* | ||
|---|---|---|---|---|---|---|
| QIB (Ex Anchor) | 1.19 | 11,76,000 |
|
15.978 | ||
| Non-Institutional Buyers | 3.63 | 8,82,000 | 32,05,200 | 36.539 | ||
| bNII (bids above ₹10L) | 5.00 | 5,88,000 | 29,41,200 | 33.530 | ||
| sNII (bids below ₹10L) | 0.90 | 2,94,000 | 2,64,000 | 3.010 | ||
| Retail Investors | 1.02 | 20,59,200 | 21,07,200 | 24.022 | ||
| Total** | 1.63 | 41,17,200 | 67,14,000 | 76.540 |
*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.
Mahamaya Lifesciences IPO Anchor Allocation
| Anchor Bid Date | 10 November 2025 |
| Shares Offered | 17,52,000 |
| Anchor portion Size (In ₹ Cr.) | 19.97 |
| Anchor lock-in period end date for 50% shares (30 Days) | 14 December 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | 12 December 2026 |
| Particulars (In ₹Crores.) | FY25 | FY24 | FY23 |
| Revenue (₹ Crores) | 264.14 | 161.57 | 137.07 |
| EBITDA (₹ Crores) | 24.64 | 13.35 | 8.91 |
| PAT (₹ Crores) | 12.9415 | 5.21 | 3.75 |
| Particulars (In ₹Crores.) | FY25 | FY24 | FY23 |
| Total Assets (₹ Crores) | 188.35 | 112.06 | 77.88 |
| Equity Share Capital (₹ Crores) | 17.76 | 1.24 | 1.24 |
| Total Borrowings (₹ Crores) | 188.35 | 112.06 | 77.88 |
| Particulars (In ₹Crores.) | FY25 | FY24 | FY23 |
| Operating Activities (₹ Crores) | 0.52 | 22.66 | 1.06 |
| Investing Activities (₹ Crores) | 8.28 | 2.00 | 2.79 |
| Financing Activities (₹ Crores) | 8.52 | 24.34 | 2.35 |
| Net Increase/Decrease in Cash (₹ Crores) | 1.16 | 0.76 | 0.31 |
Strengths
• Established presence in agrochemical formulations with in-house manufacturing.
• Experienced promoter group and management with long industry experience.
• Focus on integrated crop protection solutions including bio-based and eco-friendly products.
• Well-established distributor network across multiple Indian states and international markets
Weaknesses
• Relatively small scale compared to larger industry players.
• Limited formal market history as this is the first public equity offer.
• Moderate financial leverage with some indebtedness.
• Dependence on regulatory approvals and registration processes for new products.
Opportunities
• Expansion of manufacturing capacity and technical plant funded by IPO proceeds.
• Growing domestic and international market demand for sustainable agrochemical products.
• Increasing registration of new molecules to diversify product portfolio.
• Enhancing presence in high-growth bio-fertilizer and bio-stimulant segments.
Threats
• Regulatory risks related to pesticide approvals and environmental compliance.
• Intense competition from established agrochemical companies.
• Price volatility and input cost fluctuations impacting margins.
• Potential market liquidity and trading risks post-IPO due to SME platform listing.
• Strong revenue growth with ₹267 crore in FY25 and expanding profitability.
• Early mover advantage in eco-friendly bio-based crop care products.
• Established distributor network across multiple Indian states and international exports.
• IPO proceeds to fund capacity expansion and new technical manufacturing plant.
Mahamaya Lifesciences Ltd IPO shows strong growth potential with revenue rising from ₹90.16 crore in FY22 to ₹267.17 crore in FY25 and a solid PAT of ₹12.94 crore. The company leverages early mover advantage in eco-friendly crop care products and an expanding dealer network. Listing on BSE SME offers market access for scaling operations and capital infusion for capacity expansion.
- Companies
- Type
- Opening On
-
Wakefit Innovations
- Mainboard
- 08th Dec
- Pre-Book
-
Corona Remedies
- Mainboard
- 08th Dec
- Pre-Book
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
By proceeding, you agree to all T&C*
FAQs
Mahamaya LifesciencesLtd IPO opens from November 11, 2025 to November 13, 2025.
The size of Mahamaya LifesciencesLtd IPO is ₹70.44 Cr.
The price band of Mahamaya LifesciencesLtd IPO is fixed at ₹108 to ₹114 per share.
To apply for Mahamaya LifesciencesLtd IPO, follow the steps given below:
● Login to your 5paisa demat account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Mahamaya LifesciencesLtd IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
You will receive a mandate notification to block funds in your UPI app.
The minimum lot size of Mahamaya LifesciencesLtd IPO is of 2,400 shares and the investment required is ₹2,59,200.
The share allotment date of Mahamaya LifesciencesLtd IPO is November 14, 2025
The Mahamaya LifesciencesLtd IPO will likely be listed on November 18, 2025.
The book running lead managers for Mahamaya LifesciencesLtd IPO is Oneview Corporate Advisors Pvt. Ltd.
Mahamaya LifesciencesLtd IPO plans to utilise the raised capital from the IPO for:
• Purchase of Equipment for existing Formulation plant
• Funding capital expenditure towards setting up of a new technical manufacturing plant.
• Construction of Warehouse Building and Purchase of Machinery
• Funding working capital requirement of our Company
• General Corporate purposes